Advertisement Aurobindo Pharma names new CEO for API & CRAMS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Aurobindo Pharma names new CEO for API & CRAMS

Aurobindo Pharma has named N Govindarajan as the CEO (APIs & CRAMS) of the company with effect from 7 October 2010.

Govindarajan will oversee active pharmaceutical ingredients (APIs) Operations and CRAMS development business at Aurobindo. He will be reporting to the managing director of the company.

Most recently, Govindarajan worked as the managing director & CEO of Shasun Pharmaceuticals.

Aurobindo Pharma chairman Ramprasad Reddy said that they are happy to welcome Govindarajan as an integral part of the firms family.